Majority of Cancer Patients with COVID-19 Have similar Immune Response to People Without Cancer

March 22, 2021 (BRONX, NY)— Most people with cancer who are infected by the novel coronavirus produce antibodies at a rate comparable to the rest of the population—but their ability to do so depends on their type of cancer and the treatments they’ve received, according to a new study by researchers atMontefiore Health System andAlbert Einstein College of Medicine. The findings, published online today inNature Cancer, may lead to better care for cancer patients, who face a heightened risk of dying from COVID-19, and suggests that cancer patients should respond well to COVID-19 vaccines.
Source: Einstein News - Category: Universities & Medical Training Source Type: news